Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 2, Pages 338-353
Publisher
Oxford University Press (OUP)
Online
2016-10-21
DOI
10.1093/jac/dkw426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
- (2016) Marco Fiorillo et al. Aging-US
- Clofazimine Inhibits the Growth of Babesia and Theileria ParasitesIn VitroandIn Vivo
- (2016) Bumduuren Tuvshintulga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory State
- (2016) Gi S. Yoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy
- (2016) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
- (2016) Puneet P. Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
- (2016) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
- (2016) Mishal Pandie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings
- (2016) Derek J. Sloan et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters
- (2016) Lindsey H.M. te Brake et al. TUBERCULOSIS
- Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
- (2016) Dirk A. Lamprecht et al. Nature Communications
- Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma
- (2016) Angela Zaccagnino et al. Oncotarget
- Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
- (2016) Scott M. Irwin et al. ACS Infectious Diseases
- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Determination of MIC Distribution and Epidemiological Cutoff Values for Bedaquiline and Delamanid in Mycobacterium tuberculosis Using the MGIT 960 System Equipped with TB eXiST
- (2015) Peter M. Keller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis
- (2015) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of Bedaquiline in Human Serum Using Liquid Chromatography-Tandem Mass Spectrometry
- (2015) Jan-Willem C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
- (2015) Ben Gold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bioluminescence for Assessing Drug Potency against Nonreplicating Mycobacterium tuberculosis
- (2015) Anthony Vocat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis
- (2015) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
- (2015) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
- (2015) Beatriz E. Ferro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Primera serie de pacientes con TB-XDR y pre-XDR tratados con esquemas que incluyeron meropenem-clavulanato en Argentina
- (2015) Domingo Palmero et al. ARCHIVOS DE BRONCONEUMOLOGIA
- In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine
- (2015) CJM Bennie et al. AUSTRALIAN VETERINARY JOURNAL
- Clofazimine analogs with antileishmanial and antiplasmodial activity
- (2015) Anna Barteselli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Bedaquiline
- (2015) Sebastiaan C. Goulooze et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- State-dependent blocking mechanism of Kv1.3 channels by the antimycobacterial drug clofazimine
- (2015) Malika Faouzi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clofazimine Induced Suicidal Death of Human Erythrocytes
- (2015) Arbace Officioso et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
- (2015) Julie V. Philley et al. CHEST
- Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis
- (2015) Onno W. Akkerman et al. CLINICAL INFECTIOUS DISEASES
- Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis: Prospective, Multicenter, Randomized Controlled Study in China
- (2015) S. Tang et al. CLINICAL INFECTIOUS DISEASES
- A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages
- (2015) Rahul K. Keswani et al. CYTOMETRY PART A
- Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug
- (2015) Nathan Geffen Developing World Bioethics
- Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
- (2015) J.-P. Lanoix et al. Disease Models & Mechanisms
- Computer-guided drug repurposing: Identification of trypanocidal activity of clofazimine, benidipine and saquinavir
- (2015) Carolina L. Bellera et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Synthetic investigational new drugs for the treatment of tuberculosis
- (2015) Yong-Soo Kwon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bedaquiline for the treatment of drug-resistant tuberculosis
- (2015) Sabine Bélard et al. Expert Review of Anti-Infective Therapy
- Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment
- (2015) Geetha Srikrishna et al. Future Microbiology
- In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid
- (2015) Alexandre López-Gavín et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates
- (2015) Zhijian Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effectiveness and safety of clofazimine and pentoxifylline in type 2 lepra reaction: a double-blind, randomized, controlled study
- (2015) Kunal Roy et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
- (2015) Erica Lessem et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000–2009
- (2015) R. van Altena et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
- (2015) N. Ndjeka et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
- (2015) C. Kuaban et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis
- (2015) Giovanni Piccaro et al. JOURNAL OF ANTIBIOTICS
- Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
- (2015) Caroline M. Pule et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of novel mutations associated with clofazimine resistance inMycobacterium tuberculosis: Table 1.
- (2015) Shuo Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bactericidal mode of action of bedaquiline
- (2015) K. Hards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evidence for the presence of clofazimine and its distribution in the healthy mouse brain
- (2015) Sooraj Baijnath et al. JOURNAL OF MOLECULAR HISTOLOGY
- Informed use of bedaquiline for tuberculosis
- (2015) Jennifer Furin LANCET
- Drug-resistance mechanisms and tuberculosis drugs
- (2015) Claudio U Köser et al. LANCET
- The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
- (2015) Laia Ruiz Mingote et al. LANCET
- Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition
- (2015) Rahul K. Keswani et al. MOLECULAR PHARMACEUTICS
- Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion
- (2015) Gi S. Yoon et al. MOLECULAR PHARMACEUTICS
- Asymmetric Synthesis and Absolute Configuration Assignment of a New Type of Bedaquiline Analogue
- (2015) Chang-Jiang Qiao et al. MOLECULES
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinfectives targeting enzymes and the proton motive force
- (2015) Xinxin Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
- (2015) Sandeep Tyagi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- La tuberculose en 2015 : du diagnostic à la détection des formes résistantes
- (2015) C. Hervé et al. REVUE DES MALADIES RESPIRATOIRES
- Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients
- (2015) P.F. Cariello et al. Transplant Infectious Disease
- Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates
- (2015) Lin Zou et al. TUBERCULOSIS
- An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens
- (2015) Nicole Robbins et al. Cell Reports
- Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
- (2015) Gordana Panic et al. PLoS Neglected Tropical Diseases
- Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization
- (2015) Hannah Priyadarshini Gideon et al. PLoS Pathogens
- Primera serie de pacientes con TB-XDR y pre-XDR tratados con esquemas que incluyeron meropenem-clavulanato en Argentina
- (2015) Domingo Palmero et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Effects of clofazimine on planktonic and biofilm growth of Mycobacterium tuberculosis and Mycobacterium smegmatis
- (2015) Maborwa T. Mothiba et al. Journal of Global Antimicrobial Resistance
- New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
- (2015) Grania Brigden et al. Infection and Drug Resistance
- Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline
- (2015) L. Preiss et al. Science Advances
- Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?
- (2015) Stephen K. Field Therapeutic Advances in Chronic Disease
- The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress
- (2015) Ping Lu et al. Scientific Reports
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein
- (2014) Yasuhiro Horita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas
- (2014) Scott M. Irwin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Pharmacokinetic Interaction between Repeated Doses of Rifapentine or Rifampin and a Single Dose of Bedaquiline in Healthy Adult Subjects
- (2014) Helen Winter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Efflux Pump Inhibitor Timcodar Improves the Potency of Antimycobacterial Agents
- (2014) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection
- (2014) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort
- (2014) L. Guglielmetti et al. CLINICAL INFECTIOUS DISEASES
- In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
- (2014) S. Singh et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bedaquiline: A New Hope to Treat Multi-Drug Resistant Tuberculosis
- (2014) Rahul Patel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment: TABLE 1
- (2014) Akos Somoskovi et al. EUROPEAN RESPIRATORY JOURNAL
- Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India
- (2014) Z. F. Udwadia et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients
- (2014) K. J. M. Aung et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
- (2014) A. Piubello et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study
- (2014) N. Padayatchi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
- (2014) E. M. Svensson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bone distribution study of anti leprotic drug clofazimine in rat bone marrow cells by a sensitive reverse phase liquid chromatography method
- (2014) Cheruvu Hanumanth Srikanth et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents
- (2014) Dongfeng Zhang et al. MOLECULES
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
- (2014) Marylee V. Worley et al. PHARMACOTHERAPY
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
- (2014) Andrew J Nunn et al. Trials
- Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
- (2014) Ashish Kumar Kakkar et al. TUBERCULOSIS
- A Mycobacterium tuberculosis Cytochrome bd Oxidase Mutant Is Hypersensitive to Bedaquiline
- (2014) M. Berney et al. mBio
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Management of drug-resistant TB in patients with HIV co-infection
- (2014) Graeme Meintjes Journal of the International AIDS Society
- Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
- (2014) Thomas J Hwang et al. BMJ Open
- New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
- (2014) Eric Leibert et al. Therapeutics and Clinical Risk Management
- Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice
- (2013) Jacques H. Grosset et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
- (2013) Shashank Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rational drug design based synthesis of novel arylquinolines as anti-tuberculosis agents
- (2013) Puneet P. Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Systematic review of clofazimine for the treatment of drug-resistant tuberculosis [Review article]
- (2013) M. Gopal et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Rising to the challenge: new therapies for tuberculosis
- (2013) Emily B. Wong et al. TRENDS IN MICROBIOLOGY
- Multiscale Distribution and Bioaccumulation Analysis of Clofazimine Reveals a Massive Immune System-Mediated Xenobiotic Sequestration Response
- (2012) Jason Baik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhaled Microparticles Containing Clofazimine Are Efficacious in Treatment of Experimental Tuberculosis in Mice
- (2012) R. K. Verma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Antibiotics Targeting Respiratory ATP Synthesis in Gram-Positive Pathogenic Bacteria
- (2012) Wendy Balemans et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
- (2012) Ming Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters
- (2012) J. Xu et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The chemotherapy of tuberculosis: past, present and future [State of the art]
- (2012) D. Mitchison et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
- (2012) Teesta Dey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?
- (2012) K. E. Dooley et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis
- (2012) Dongfeng Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
- (2012) Robert S. Wallis et al. PLoS One
- Macrophages Sequester Clofazimine in an Intracellular Liquid Crystal-Like Supramolecular Organization
- (2012) Jason Baik et al. PLoS One
- Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals
- (2012) Sarah Schmidt Grant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
- (2011) Yu Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis
- (2011) Rinki Kapoor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine in the treatment of multidrug-resistant tuberculosis
- (2011) H.-B. Xu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bicephalic amphiphile architecture affects antibacterial activity
- (2011) Jade E. LaDow et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
- (2011) D. Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- Clofazimine: current status and future prospects
- (2011) M. C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Imaging of Intracellular Drug–Membrane Aggregate Formation
- (2011) Jason Baik et al. MOLECULAR PHARMACEUTICS
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- F1F0-ATP synthases of alkaliphilic bacteria: Lessons from their adaptations
- (2010) David B. Hicks et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- (2010) R. Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
- (2010) Takahiro Yano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- (2010) Jasvir Dhillon et al. TUBERCULOSIS
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Diarylquinoline R207910 Is Bactericidal against Mycobacterium leprae in Mice at Low Dose and Administered Intermittently
- (2009) R. Gelber et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis
- (2009) Ram Shankar Upadhayaya et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the ATPase activity of the catalytic portion of ATP synthases by cationic amphiphiles
- (2008) Manuel J. Datiles et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas
- (2008) S. Hong et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes
- (2008) Yunzhao R. Ren et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now